Biofrontera Inc (BFRI)
1.05
-0.01
(-0.94%)
USD |
NASDAQ |
May 24, 16:00
1.05
0.00 (0.00%)
After-Hours: 20:00
Biofrontera Profit Margin (Quarterly): -131.9% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -131.9% |
| December 31, 2023 | 33.28% |
| September 30, 2023 | -71.29% |
| June 30, 2023 | -168.2% |
| March 31, 2023 | -85.63% |
| December 31, 2022 | -27.45% |
| September 30, 2022 | -59.37% |
| June 30, 2022 | -19.07% |
| Date | Value |
|---|---|
| March 31, 2022 | 57.03% |
| December 31, 2021 | -158.2% |
| September 30, 2021 | -369.5% |
| June 30, 2021 | -62.53% |
| March 31, 2021 | -74.49% |
| December 31, 2020 | -2.17% |
| September 30, 2020 | -91.79% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-369.5%
Minimum
Sep 2021
57.03%
Maximum
Mar 2022
-82.09%
Average
-71.29%
Median
Sep 2023
Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 10.76% |
| Xtant Medical Holdings Inc | -15.79% |
| Asensus Surgical Inc | -2.00K% |
| Myomo Inc | -102.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -474.3% |
| Return on Assets | -69.77% |
| Return on Invested Capital | -345.6% |
| Gross Profit Margin (Quarterly) | 47.98% |
| Operating Margin (Quarterly) | -69.10% |
| Return on Net Operating Assets | -107.4% |